Cutler Group LP Beyond Spring Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.56 - $2.61 $96 - $448	-172 Reduced 2.83%	5,897 $11,000
Q3 2022 Oct 25, 2022	SELL	$1.06 - $1.81 $6,811 - $11,631	-6,426 Reduced 51.43%	6,069 $6,000
Q2 2022 Aug 04, 2022	BUY	$1.13 - $2.66 $4,784 - $11,262	4,234 Added 51.25%	12,495 $17,000
Q1 2022 Apr 14, 2022	SELL	$1.68 - $5.01 $43,564 - $129,914	-25,931 Reduced 75.84%	8,261 $18,000
Q4 2021 Jan 18, 2022	BUY	$4.02 - $16.84 $68,420 - $286,616	17,020 Added 99.11%	34,192 $154,000

Q3 2021 Oct 26, 2021	BUY	$9.26 - $31.31 $159,012 - $537,655	17,172 New	17,172 $270,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.